S.E.E.D. Planning Group LLC Abb Vie Inc. Transaction History

S.E.E.D. Planning Group LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 21, 2021	BUY	$106.4 - $120.78 $95,760 - $108,702	900 Added 38.63%	3,230 $348,000
Q2 2021 Jul 14, 2021	BUY	$105.21 - $117.21 $10,521 - $11,721	100 Added 4.48%	2,330 $262,000
Q4 2020 Jan 19, 2021	BUY	$80.49 - $108.67 $179,492 - $242,334	2,230 New	2,230 $239,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of S.E.E.D. Planning Group LLC, based on Form 13F filings with the SEC.

Stay updated on S.E.E.D. Planning Group LLC with notifications on news.